Media contact: Yvonne Taunton
The virtual symposium will cover topics such as gene editing and cardiac stem cells in heart failure and feature the National Academy of Medicine president as a keynote speaker.Join the 2020 Progenitor Cell Translation Consortium Cardiovascular Bioengineering Symposium to be co-hosted by the University of Alabama at Birmingham’s Department of Biomedical Engineering on Monday, Dec. 5, via Zoom.
The symposium will focus on cardiac gene and cell therapy topics, including areas of gene editing, induced pluripotent stem cells, cardiac stem cells in the context of heart failure, cardiovascular bioengineering, vascular tissue engineering, cardiac development, exosomes, microRNAs and mitochondria.
This collaborative conference is co-organized by Jay Zhang, chair of the UAB Department of Biomedical Engineering, and Wolfram Zimmerman, Ph.D., of the University Medical Center Göttingen. Due to the worldwide outbreak of coronavirus, the symposium will be held in a virtual format via Zoom for the first time.
The event will feature a keynote address by Victor Dzau, M.D., president of the National Academy of Medicine and professor of Medicine at Duke University. He will speak on “The Future of Heart Failure Therapy/Paracrine Mechanism of Stem Cell Therapy.” Dzau is a prominent world health leader and advises governments, corporations and universities worldwide. He has also made a major impact on health and medicine through his seminal research and leadership in health innovation.
Registration is free and will be required for access to the symposium. Register online.